We are looking for young people 2 to 17 years of age to join a Crohn’s disease trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderate to severe CD (including associated symptoms such as cramps, joint pain, diarrhea, malnutrition and/or eye pain), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing CD and UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, diarrhea, rectal pain, frequent fevers, and/or liver disease associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for teen to join a CD study to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or Crohn’s and ulcerative colitis (including associated symptoms such as long-term diarrhea, stomach pain, bloody stool, frequent fevers and/or liver disease), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local research study is testing a potential new medication to see if it may reduce fatigue, joint pain, rectal pain, weight loss, and/or joint pain associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2 to 17 years old to join a UC clinical research study to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or moderate to severe CD (including associated symptoms such as abdominal cramping, perianal fistula, constant need to poop, frequent fevers and/or canker sores), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce cramps, failure to thrive, rectal pain, weight loss, and/or anemia associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) clinical research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or UC (including associated symptoms such as abdominal pain and cramps, kidney stones, bloody stool, chronic fatigue and/or joint pain), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce rectal bleeding, persistent diarrhea, rectal pain, frequent fevers, and/or anemia associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for 2 to 17 years old to join a Crohn’s disease (CD) trial to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or CD and UC (including associated symptoms such as bloody diarrhea, fatigue, rectal pain, frequent fevers and/or anemia), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce painful joints, mouth sores, constant need to poop, weight loss, and/or joint pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.